The deal closes in week and you need to assess the value of the IP. What next? How much diligence is due? IP due diligence is often associated with investment or acquisition, but also arises in a variety of other contexts, including product launch, licensing, and even litigation. Regardless of the scenario, inadequate due diligence results in wasted resources—investment in technology that carries a significant risk of infringement, easy design-around, or non-transferable rights. Additionally, due diligence often carries demanding time constraints, business pressures, and budget timelines. Join us as we discuss strategies and best practices for efficient and cost-effective due diligence, as well as identifying and assessing risks.
Topics include:
Date:
Thursday, 5 October 2017
Location:
Finnegan
16 Old Bailey
London EC4M 7EG
Time:
14:00-14:15 Registration
14:15-16:45 Seminar
16:45-17:00 Questions & networking
Speakers:
Clare A. Cornell
Anthony C. Tridico Ph.D.
Leythem A. Wall
Admission is free, but space is limited. Please register early.
Webinar
Obviousness of Biologics Inventions: Strategies for Biologics Claims in the U.S., Europe, and China
May 28,2024
Webinar
Workshop
Life Sciences Workshop: Updates and Key Trends in Pharmaceutical and Biotechnology IP Law
May 2, 2024
Cambridge
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.
We use cookies on this website to provide you with the best user experience. By accepting cookies, you agree to our use of cookies. Please note that if you opt not to accept or if you disable cookies, the “Your Finnegan” feature on this website will be disabled as well. For more information on how we use cookies, please see our Privacy Policy.
Finnegan is thrilled to announce the launch of our new blog, Ad Law Buzz, devoted solely to breaking news, developments, trends, and analysis in advertising law.